Category - Executive Moves

Executive Moves

RNADD adds renowned pro sports team physician Michael Farber to advisory board

Closely-held RNA Disease Diagnostics appointed board-certified internist and professional sports physician, Michael Farber, M.D., to its advisory board. Dr. Farber is the medical director of executive health at...

September 2, 2021

Executive Moves

iBio names biotech veteran Chip Clark to the board

iBio (NYSE:IBIO) appointed William (Chip) Clark to the board, effective immediately. Mr. Clark has more than 30 years of biotechnology and pharmaceutical experience, with a focus on business development...

August 26, 2021

Executive Moves

IntelGenx strengthens board with atai appointments of Dr. Srinivas Rao and Frank Stegert

IntelGenx Technologies (TSXV:IGX; OTCQB:IGXT) named Dr. Srinivas (Srini) Rao, M.D., Ph.D., and Frank Stegert to the board, reflecting a previously disclosed purchaser rights agreement with atai Life Sciences AG. With...

August 4, 2021

Executive Moves

EyeGate Pharma names Brian Strem as president and CEO

EyeGate Pharmaceuticals (NASDAQ:EYEG) appointed Brian Strem, Ph.D., as president, CEO and a director, effective immediately. He replaces acting CEO, Franz Obermayr, Ph.D., who reassumes his position as EVP clinical...

July 28, 2021

Executive Moves

Kyle Mikson joins Canaccord Genuity as director, senior equity research

Canaccord Genuity appointed Kyle Mikson as a director, senior equity research analyst covering the life science tools and diagnostics sector. Mr. Mikson will focus on expanding the firm’s footprint on important...

July 9, 2021

Executive Moves

Healthcare veteran Richard Ganz joins RNA Disease Diagnostics board

Closely-held RNA Disease Diagnostics appointed Robert Ganz, a healthcare veteran with more than 40 years of executive experience in venture-backed startups and international healthcare companies, to the board. Mr. Ganz...

July 8, 2021

Executive Moves

Q32 Bio names Adam Cutler as CFO

Closely-held Q32 Bio appointed Adam Cutler as chief financial officer, with responsibility for all aspects of its financial strategy and operations. Mr. Cutler has more than 20 years of experience in corporate finance...

July 7, 2021

Executive Moves

Sernova names Frank Shannon as VP clinical development, regulatory affairs

Sernova (TSXV:SVA; OTC:SEOVF; FSE/XETRA:PSH) appointed 25-year pharmaceutical industry executive, Frank Shannon, as VP of clinical development and regulatory Affairs. Mr. Shannon most recently served as VP clinical...

June 30, 2021

Executive Moves

Talkiatry names Jared Camins as CTO

Talkiatry appoints Jared Camins as Chief Technology Officer Closely-held Talkiatry, a leading mental health care provider that connects people with high-quality psychiatric care via telehealth or in-person, appointed...

June 22, 2021

Executive Moves

PharmaJet names Paul LaBarre as VP global business development

PharmaJet named Paul LaBarre as VP of global business development to lead business development and commercialization strategies, replacing Melissa Malhame, who transitioned to a strategic advisory role for the company...

June 15, 2021

Category - Executive Moves

RNADD adds renowned pro sports team physician Michael Farber to advisory board

iBio names biotech veteran Chip Clark to the board

IntelGenx strengthens board with atai appointments of Dr. Srinivas Rao and Frank Stegert

EyeGate Pharma names Brian Strem as president and CEO

Kyle Mikson joins Canaccord Genuity as director, senior equity research

Healthcare veteran Richard Ganz joins RNA Disease Diagnostics board

Q32 Bio names Adam Cutler as CFO

Sernova names Frank Shannon as VP clinical development, regulatory affairs

Talkiatry names Jared Camins as CTO

PharmaJet names Paul LaBarre as VP global business development

General

More